APT Medical Inc.
SSE:688617.SS
392.12 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 564.277 | 540.973 | 523.869 | 539.169 | 449.495 | 431.953 | 425.724 | 438.273 | 349.713 | 328.691 | 331.67 | 290.146 | 265.511 | 235.293 | 208.655 | 223.899 | 160.842 | 156.884 | 129.643 | 121.207 | 71.702 | 119.384 | 100.202 |
| Cost of Revenue
| 151.862 | 155.53 | 143.636 | 157.623 | 127.425 | 138.641 | 124.653 | 120.149 | 102.585 | 92.747 | 92.809 | 84.358 | 80.252 | 74.041 | 63.818 | 67.196 | 47.788 | 44.851 | 36.641 | 37.572 | 23.063 | 33.496 | 28.471 |
| Gross Profit
| 412.415 | 385.443 | 380.233 | 381.546 | 322.07 | 293.312 | 301.071 | 318.124 | 247.128 | 235.944 | 238.861 | 205.788 | 185.259 | 161.252 | 144.837 | 156.703 | 113.053 | 112.033 | 93.002 | 83.635 | 48.639 | 85.888 | 71.731 |
| Gross Profit Ratio
| 0.731 | 0.712 | 0.726 | 0.708 | 0.717 | 0.679 | 0.707 | 0.726 | 0.707 | 0.718 | 0.72 | 0.709 | 0.698 | 0.685 | 0.694 | 0.7 | 0.703 | 0.714 | 0.717 | 0.69 | 0.678 | 0.719 | 0.716 |
| Reseach & Development Expenses
| 73.97 | 87.683 | 68.963 | 62.907 | 65.615 | 64.292 | 59.389 | 56.321 | 52.607 | 40.554 | 45.952 | 43.888 | 44.483 | 53.851 | 30.736 | 28.705 | 21.585 | 21.966 | 20.708 | 16.085 | 13.14 | 22.839 | 0 |
| General & Administrative Expenses
| 30.391 | -38.367 | 53.327 | -9.992 | 24.258 | -36.557 | 48.813 | -4.547 | 17.874 | 14.322 | 38.149 | -3.317 | 17.393 | -29.356 | 34.531 | 2.761 | 11.315 | 1.744 | 4.762 | -3.554 | 9.426 | 1.489 | 0 |
| Selling & Marketing Expenses
| 98.075 | -107.76 | 190.866 | 89.34 | 87.85 | 71.688 | 82.271 | 81.517 | 69.224 | 61.776 | 68.512 | 55.912 | 54.829 | 66.447 | 48.246 | 46.372 | 35.244 | 43.27 | 28.564 | 24.13 | 17.796 | 29.265 | 0 |
| SG&A
| 128.465 | -146.128 | 252.274 | 105.319 | 112.153 | 84.752 | 131.084 | 76.97 | 87.099 | 76.098 | 106.66 | 52.595 | 72.222 | 37.091 | 82.777 | 49.133 | 46.559 | 45.013 | 33.326 | 20.576 | 27.222 | 30.754 | 0 |
| Other Expenses
| -5.689 | 279.506 | -140.533 | -2.001 | 0.09 | -16.105 | 0.146 | -0.839 | -5.957 | -4.06 | -20.543 | 16.688 | 2.57 | -0.711 | -0.17 | -0.213 | 0.145 | 1.993 | 0.006 | -0.231 | -0.001 | -0.65 | -52.828 |
| Operating Expenses
| 196.746 | 221.061 | 180.704 | 170.227 | 177.678 | 165.148 | 155.546 | 162.325 | 133.749 | 112.592 | 132.069 | 113.17 | 119.274 | 121.004 | 99 | 85.537 | 69.651 | 70.993 | 58.044 | 47.206 | 38.026 | 60.142 | -52.828 |
| Operating Income
| 215.669 | 164.382 | 199.529 | 211.319 | 144.392 | 128.164 | 162.804 | 176.38 | 115.829 | 107.074 | 114.388 | 101.39 | 74.136 | 37.238 | 53.961 | 78.697 | 52.606 | 37.491 | 35.307 | 35.961 | 10.687 | 23.643 | 18.902 |
| Operating Income Ratio
| 0.382 | 0.304 | 0.381 | 0.392 | 0.321 | 0.297 | 0.382 | 0.402 | 0.331 | 0.326 | 0.345 | 0.349 | 0.279 | 0.158 | 0.259 | 0.351 | 0.327 | 0.239 | 0.272 | 0.297 | 0.149 | 0.198 | 0.189 |
| Total Other Income Expenses Net
| -1.849 | -5.181 | -3.594 | -1.208 | 13.29 | -3.184 | 0.146 | -0.839 | -0.17 | -2.036 | 0.094 | 0.313 | 0.001 | -0.711 | -0.17 | -0.213 | 0.145 | 1.993 | 0.006 | -0.231 | -0.001 | -0.65 | -0.023 |
| Income Before Tax
| 213.82 | 159.201 | 195.935 | 228.583 | 155.389 | 143.015 | 162.95 | 175.541 | 115.659 | 105.038 | 114.254 | 101.703 | 74.137 | 36.527 | 53.791 | 78.484 | 52.751 | 39.484 | 35.314 | 35.73 | 10.687 | 22.993 | 18.879 |
| Income Before Tax Ratio
| 0.379 | 0.294 | 0.374 | 0.424 | 0.346 | 0.331 | 0.383 | 0.401 | 0.331 | 0.32 | 0.344 | 0.351 | 0.279 | 0.155 | 0.258 | 0.351 | 0.328 | 0.252 | 0.272 | 0.295 | 0.149 | 0.193 | 0.188 |
| Income Tax Expense
| 33.684 | 23.084 | 14.502 | 30.392 | 19.822 | 16.651 | 19.021 | 21.69 | 16.875 | 12.528 | 15.875 | 15.453 | 11.119 | -2.901 | 8.506 | 12.069 | 9.028 | 2.586 | 6.175 | 5.591 | 2.667 | 1.08 | 78.936 |
| Net Income
| 183.152 | 145.005 | 185.586 | 202.417 | 140.144 | 130.677 | 145.852 | 154.709 | 102.687 | 97.443 | 101.704 | 92.066 | 66.806 | 45.893 | 47.175 | 67.659 | 47.195 | 39.201 | 31.449 | 31.385 | 8.741 | 21.285 | 17.105 |
| Net Income Ratio
| 0.325 | 0.268 | 0.354 | 0.375 | 0.312 | 0.303 | 0.343 | 0.353 | 0.294 | 0.296 | 0.307 | 0.317 | 0.252 | 0.195 | 0.226 | 0.302 | 0.293 | 0.25 | 0.243 | 0.259 | 0.122 | 0.178 | 0.171 |
| EPS
| 1.89 | 1.498 | 1.91 | 2.09 | 2.1 | 1.95 | 2.18 | 2.32 | 1.54 | 1.46 | 1.53 | 1.38 | 1 | 0.64 | 0.77 | 1.1 | 0.77 | 0.64 | 0.51 | 0.61 | 0.17 | 0.41 | 0.33 |
| EPS Diluted
| 1.88 | 1.49 | 1.91 | 2.09 | 2.07 | 1.97 | 2.15 | 2.28 | 1.52 | 1.46 | 1.51 | 1.36 | 0.99 | 0.64 | 0.77 | 1.1 | 0.77 | 0.64 | 0.51 | 0.61 | 0.17 | 0.41 | 0.33 |
| EBITDA
| 214.985 | 159.633 | 198.986 | 249.883 | 177.032 | 162.213 | 183.262 | 190.942 | 135.663 | 124.889 | 128.321 | 113.84 | 85.745 | 47.482 | 64.483 | 84.874 | 59.196 | 44.029 | 40.777 | 41.472 | 14.204 | 27.953 | -60.295 |
| EBITDA Ratio
| 0.381 | 0.295 | 0.38 | 0.463 | 0.394 | 0.376 | 0.43 | 0.436 | 0.388 | 0.38 | 0.387 | 0.392 | 0.323 | 0.202 | 0.309 | 0.379 | 0.368 | 0.281 | 0.315 | 0.342 | 0.198 | 0.234 | -0.602 |